NPI 1588636484 — Billing Profile & Reimbursement Data
NPI 1588636484 · XX · healthcare
Customize your policy alerts
Sign up for NPI 1588636484 — Billing Profile & Reimbursement Data policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
NPI 1588636484 is a healthcare provider located in Unspecified Location. This profile covers 24 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services. Note: "XX" is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; claims coded under it are grouped and benchmarked here the same way a traditional state would be.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | NPI 1588636484 |
| Address | |
| City | |
| State | XX (Unspecified Location) |
| ZIP | |
| Taxonomy | N/A |
| NPI Enumerated | |
| NPI Deactivated | August 20, 2026 |
(source: CMS Medicare & Medicaid claims data)
Key Findings
This provider is effectively a single‑payer Medicare practice: total Medicare revenue is $3.2M while there is no Medicaid billing on file. The provider’s billing is highly concentrated — the precomputed top 3 Medicare codes account for 77.4% of total Medicare revenue — indicating most revenue is tied to a small set of ophthalmology treatments.
The code mix strongly indicates an ophthalmology/retina specialty focused on intravitreal biologic treatments and diagnostic imaging. The top codes are J0178 (aflibercept injections), J2777 (faricimab injections), and 67028 (isolated intravitreal injection procedure), and their descriptions point to clinic‑based, injection‑centric retinal care rather than broad multispecialty services.
Revenue concentration is dominated by a single high‑value drug: J0178 accounts for $1.8M and 54.4% of the provider’s Medicare revenue, while J2777 contributes $523.7K (16.2%) and contributes $221.5K (6.9%); together these top three drive the documented 77.4% share. This pattern implies a heavy reliance on a small set of injectable therapeutics and the associated administration procedure for the bulk of revenue.
Medicare: Total Revenue Breakdown by CPT/HCPCS Code
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
Medicare: Complete Services Breakdown
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
24 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 2,550 | $690 | $1.8M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 18,060 | $30 | $523.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 2,490 | $90 | $221.5K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,340 | $120 | $160.2K |
| J2778 | Injection, ranibizumab, 0.1 mg | 600 | $180 | $108.9K |
| J7999 | Compounded drug, not otherwise classified | 1,190 | $70 | $83.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 3,000 | $30 | $81.1K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 820 | $80 | $68K |
| J3590 | Unclassified biologics | 30 | $1,930 | $63.6K |
| J3490 | Unclassified drugs | 40 | $1,670 | $58.3K |
Showing 1–10 of 24
Medicare: Competitive Analysis & Benchmarks
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes. Note: this provider's state, "XX," is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; the State panel below benchmarks against other providers coded under the same designation.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Frequently Asked Questions
References
- 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
- 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.